XML 70 R61.htm IDEA: XBRL DOCUMENT v3.23.3
FAIR VALUE MEASUREMENTS - Narrative (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration $ 293,777,000   $ 293,777,000   $ 306,927,000
Gain on sale of investments     5,400,000    
Venture capital investment fund          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Investment owned, at fair value 5,100,000   5,100,000   $ 3,900,000
Committed capital     17,500,000    
Committed capital callable $ 12,400,000   $ 12,400,000    
Product development and other milestone-based payments | Weighted average | Measurement Input, Probability of Success          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration liability, measurement input 0.91   0.91   0.91
Product development and other milestone-based payments | Weighted average | Measurement Input, Present-value Factor          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration liability, measurement input 0.067   0.067   0.062
Foreign exchange forward          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Derivative, notional amount $ 33,300,000   $ 33,300,000   $ 22,300,000
Derivative, fair value 0   0   0
Gain (Loss) on derivative instruments, net, pretax 0 $ 0 0 $ 0  
Significant Unobservable Inputs (Level 3) | Fair value, nonrecurring          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Investment owned, at fair value 31,700,000   31,700,000   39,800,000
Impairment loss, annual amount   $ 10,000,000   $ 10,000,000  
Thrive and Ashion | Fair value          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration 293,800,000   293,800,000   $ 306,800,000
Thrive and Ashion | Revenue and Other Performance-based Payments          
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]          
Contingent consideration $ 0   $ 0